Clinical trials
Withdrawn Heart Failure trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
96 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 8 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 9 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 10 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 96 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Pennsylvania | 4 |
| Brigham and Women's Hospital | 3 |
| Duke University | 3 |
| Massachusetts General Hospital | 3 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| Sarfez Pharmaceuticals, Inc. | 3 |
| University of California, San Francisco | 3 |
| University of Florida | 3 |
| University of Louisville | 3 |
| Abbott Medical Devices | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 96 |
| Cardiovascular Diseases | 6 |
| Hypertension, Pulmonary | 5 |
| Pulmonary Disease, Chronic Obstructive | 5 |
| Arrhythmias, Cardiac | 4 |
| Heart Failure, Systolic | 4 |
| Cardiomyopathies | 3 |
| Diabetes Mellitus | 3 |
| Frailty | 3 |
| Heart Diseases | 3 |
Trials
Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.